Skip to main content
SpringerLink
Log in

Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Effects of renal insufficiency on the pharmacokinetics of vinpocetine and its main metabolite, apovincaminic acid (AVA) were investigated in the present study. The elimination rate constant, half-life, clearance, area under the curve and volume of distribution were measured and compared with reported values for subjects with normal renal function. Previous investigations have shown that the elimination half life of vinpocetine was 2.54±0.48 hours and half-life of AVA was 3.66±1.56 hours in healthy volunteers after i. v. administration of 10 mg vinpocetine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Polgâr, M., Vereczkey, L.; in A. Frigerio (Editor), (1983): Recent Developments on Chromatography in Biochemistry, Medicine and Environmental Research, 1 (Proc. 1st Int. Symp., Venice, June 16–17, 1981), Elsevier, Amsterdam, Oxford, New York.

    Google Scholar 

  2. Polgár, M., Vereczkey, L. (1982): Determination of apovincaminic acid in human plasma by gas-liquid chromatography. J. Chrom. 241, 29–32.

    Article  Google Scholar 

  3. Benakis, A., Plessas, Ch., Sugnaux, F. R., Bouvier, Cl., Reber, G. and Vereczkey, L. (1983): Pharmacokinetics of a new vasodilator drug, Vinpocetine (Cavinton ) in man. II. World Conference on Clinical Pharmacology and Therapeutics, Washington, USA, July 31–August 5, 1983.

  4. Polgár, M., Vereczkey, L. (1983): Pharmacokinetics of vinpocetine after i.V., i-.m. and oral administration. Company Report No. RGD 27441.

  5. Kozma, M., Vereczkey, L. (1982): Investigation of the pharmacokinetics of apovincaminic acid before and after the chronic oral administration of vinpocetine. Company Report No. RGD 25244.

Download references

Author information

Authors and Affiliations

  1. Dept. of Pharmacokinetics and Drug Metabolism, Chemical Works of Gedeon Richter Ltd., P. O. Box 27, H-1475, Budapest 10, Hungary

    P. Miskolczi & L. Vereczkey

  2. II. Dept. Med., Semmelweis Med. Univ., Budapest, Hungary

    L. Szalay & CS. Göndöcs

Authors
  1. P. Miskolczi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Vereczkey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Szalay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. CS. Göndöcs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miskolczi, P., Vereczkey, L., Szalay, L. et al. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function. European Journal of Drug Metabolism and Pharmacokinetics 9, 169–175 (1984). https://doi.org/10.1007/BF03189621

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189621

Key words

Search

Navigation